Atlas Trials

Observational Study of the Switch of Metformin Alone to Metformin Combined With Repaglinide in Type 2 Diabetes

Clinical trial NCT00709917 · COMPLETED

Trial details

NCT number
NCT00709917
Sponsor
Novo Nordisk A/S
Status
COMPLETED
Study type
OBSERVATIONAL
DiabetesDiabetes Mellitus, Type 2
Start date
2007-03-01
Primary completion
2008-01-01
Enrollment
2171

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.